Sky Century Investment (SKYI) Retained Earnings (2013 - 2026)
Sky Century Investment's (SKYI) quarterly Retained Earnings came in at $713049.0 in Q2 2026, up 74.58% year-on-year from $408436.0 in Q2 2025, and up 13.23% on a QoQ basis from $629749.0 in Q1 2026.
Sky Century Investment (SKYI) Retained Earnings (2013 - 2026) Analysis & Trends
Sky Century Investment (SKYI) has 5 years of Retained Earnings data on file, last reported at $713049.0 in Q2 2026.
- On a quarterly basis, Retained Earnings rose 74.58% year-over-year to $713049.0 in Q2 2026; TTM through May 2026 was $713049.0, a 74.58% increase from a year earlier, with the FY2025 full-year figure at -$922691.0, down 341.38% from the prior year.
- Retained Earnings for Q2 2026 stood at $713049.0, up from $629749.0 in the prior quarter.
- Over the last five years, Retained Earnings for SKYI reached as high as $713049.0 in Q2 2026 and fell as low as -$950904.0 in Q4 2025.
- Historically, Retained Earnings has averaged -$87707.0 across 3 years, with a median of $382251.0 in 2024.
- Across the five-year window, Retained Earnings plunged 341.38% in 2025 and surged 172.07% in 2026, its largest moves.
- Year by year, Retained Earnings stood at $382251.0 in 2024, then tumbled by 348.76% to -$950904.0 in 2025, then surged by 174.99% to $713049.0 in 2026.
- Per Business Quant data, the three most recent Retained Earnings figures were $713049.0 in Q2 2026, $629749.0 in Q1 2026, and -$950904.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | 8.83 Bn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | -413.76 Mn |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Sky Century Investment | 1.06 Mn | 1.06 Mn | 26,045.00 | 713,049.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 713,049.00 |
| Feb 28, 2026 | 629,749.00 |
| Nov 30, 2025 | -950,904.00 |
| Aug 31, 2025 | -922,691.00 |
| May 31, 2025 | 408,436.00 |
| Feb 28, 2025 | -873,839.00 |
| Aug 31, 2024 | 382,251.00 |
| Feb 28, 2014 | -37,535.00 |
| Nov 30, 2013 | 5,082.00 |
| Aug 31, 2013 | -27,721.00 |
| May 31, 2013 | -1.12 Mn |